Business Wire

YESWEHACK

10.3.2022 09:02:05 CET | Business Wire | Press release

Share
Telenor Sweden to Use Ethical Hackers to Dial-Up Cybersecurity to the Max in Partnership With YesWeHack

Telenor Sweden has partnered with YesWeHack , Europe’s leading Bug Bounty platform, to identify potential vulnerabilities on its critical telecom infrastructure and protect customer information.

Telenor is a leading telecommunications company across the Nordics and Asia with more than 188 million customers worldwide. It has mobile operations in the Nordics, including Norway, Sweden, Denmark, Finland and in Asia, including Pakistan, Bangladesh, Thailand, Malaysia, and Myanmar. Connecting customers to what matters most has been the core of its business for more than 160 years.

Telenor’s wholly owned subsidiary, Telenor Sweden, is one of the largest mobile operator in the country and provider of fixed broadband services to the consumer and business markets in Sweden.

Telecom companies maintain and operate critical communications infrastructure. This is used to transmit large amounts of sensitive consumer and business data, due to which cyberattacks against the industry are soaring. Meanwhile, the rapid advancements of new technologies such as the Internet of Things (IoT) and 5G dramatically increase the potential attack surface and threat landscape for a telco.

To protect customer data and the security of its critical infrastructure, Telenor is investing in security capabilities across its organisation as well as with its suppliers and third-party providers. It ensures the same level of control over data and infrastructure, independent of operating – or business model.

One such initiative is crowdsourcing security through a bug bounty program with YesWeHack to identify security gaps and ensure adequate data protection. Crowdsourced security will help Telenor Sweden access a diverse range of security researchers, also called hunters, with unique specialisations and in-depth industry knowledge.

“The partnership with YesWeHack is one of the ways we work with security and maybe one of the most important ones in our proactive work to stop cybercriminals. The return on investment is huge since we get access to thousands of security researchers while only paying a fraction of the cost it would take to recruit them all individually,” said Ulf Andersson, Head of Information Security at Telenor Sweden. “We are now planning to level up both the private and public program to make it even more attractive and generate more reports,” he added.

Telenor Sweden had started with a private bug bounty program where YesWeHack invited selected researchers to hack it’s infrastructure. This was followed by a public bug bounty program where the telco is now being scrutinised by the entire YesWeHack community, representing more than 35,000 global cybersecurity researchers.

“Through the YesWeHack bug bounty program, we are connected to one of the finest global networks of hackers to help us find security gaps in our infrastructure. It's all about finding vulnerabilities before anyone else. By being proactive and allowing the hacking of our infrastructure, we can find weaknesses before the criminals do and fix them,” said Marcus Lundblad, Security Engineer at Telenor Sweden.

By reducing security gaps and ensuring adequate data protection, Telenor Sweden gives its customers the comfort to share information and allow them to reap the benefits of the data-driven economy.

“Protecting people in their digital life with security at the foundation is the core value of Telenor,” said Guillaume Vassault-Houlière, CEO and Co-Founder of YesWeHack. “Telenor Sweden has achieved the position of a trusted and secure provider in all markets because of its focus on customer data protection and by defending its critical infrastructure by adopting game-changing solutions such as bug bounty,” he added.

Cybersecurity experts from Telenor Sweden will share best practices on guarding against cyber threats in a webinar on March 17th 2022. They will also share why the organisation has put bug bounty at the core of its security posture and will detail the clear benefits of a platform-driven, results-oriented and crowdsourced approach to security audits. For more information and registration visit our blog .

ABOUT YESWEHACK

Founded in 2015, YesWeHack is the #1 European Bug Bounty & VDP Platform. YesWeHack offers companies an innovative approach to cybersecurity with Bug Bounty (pay-per-vulnerability discovered), connecting more than 35,000 cybersecurity experts (ethical hackers) across 170 countries with organisations to secure their exposed scopes and reporting vulnerabilities in their websites, mobile apps, infrastructure and connected devices. YesWeHack runs private and public programs for hundreds of organisations worldwide in compliance with the strictest European regulations.

In addition to the Bug Bounty platform, YesWeHack also offers support in creating a Vulnerability Disclosure Policy (VDP), a learning platform for ethical hackers called Dojo and a training platform for educational institutions, YesWeHackEDU. For more information: www.yeswehack.com

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye